Breaking News

PackGene Biotech Breaks Ground on cGMP Biomanufacturing and Process Development Facility

Full-service operations center marks U.S. expansion for global CRO and CDMO.

PackGene Biotech Inc., an adeno-associated virus (AAV) vector contract research organization (CRO) and contract development and manufacturing organization (CDMO), announced the expansion of its U.S. services with a new cGMP biomanufacturing and processing facility in Houston. The company broke ground on the full-service operations center this week to support a growing base of U.S. customers advancing gene therapy programs. “We are excited to bring economical, reliable, and scalable A...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters